Form 4: Hims & Hers Health Executive Michael Chi Reports Stock Transactions

Chief Commercial Officer Michael Chi reports acquisition and disposal of Hims & Hers Health, Inc. Class A Common Stock and Restricted Stock Units.

Summary

• Michael Chi, Chief Commercial Officer of Hims & Hers Health, Inc., filed a Form 4 detailing changes in beneficial ownership.
• On September 13, 2024, Chi acquired 76,507 shares of Class A Common Stock through the vesting of Restricted Stock Units (RSUs).
• Also on September 13, 2024, 42,303 shares were disposed of to cover tax obligations at a price of $16.57.
• On September 17, 2024, Chi sold 25,550 shares of Class A Common Stock at a price of $16.5.
• Following these transactions, Chi directly owns 193,980 shares of Class A Common Stock and holds various RSUs.
• The sales on September 17, 2024, were executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 1, 2024.

Sentiment

Score: 5

Explanation: Neutral sentiment as the transactions are part of a pre-planned trading strategy and standard executive compensation practices.

Positives

• The vesting of RSUs indicates continued employment and contribution to the company by the executive.

Negatives

• The sale of shares by the Chief Commercial Officer could be interpreted negatively by some investors, although it is part of a pre-arranged trading plan.

Risks

• Executive stock sales, even under 10b5-1 plans, can sometimes create negative market sentiment.

Future Outlook

The document does not contain specific forward-looking statements beyond the ongoing vesting schedule of the RSUs and the execution of the 10b5-1 trading plan.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies. Monitoring these transactions can provide insights into management's perspective on the company's value and future prospects. The use of 10b5-1 plans is a standard practice to avoid insider trading accusations.

Comparison to Industry Standards

• Executive compensation packages often include stock options and restricted stock units to align management's interests with those of shareholders.
• Rule 10b5-1 trading plans are widely used by corporate insiders to sell company stock in a predetermined manner, mitigating concerns about insider trading.
• Comparing the volume and frequency of executive stock transactions at Hims & Hers Health to those of its peers (e.g., Teladoc Health, GoodRx) can provide a benchmark for assessing insider sentiment.

Stakeholder Impact

• The transactions may have a minor impact on shareholders depending on how they interpret the executive's stock sales.

Key Dates